(Reuters) - Eli Lilly on Friday was cleared of liability in the first trial involving claims that its antidepressant Cymbalta caused severe withdrawal symptoms, including suicidal thoughts and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results